Across TCGA pan-cancer cohorts, RNU7-174P Mutation is linked to patient survival in 1 of 34 cancer types, making it a survival-associated RNU7-174P data layer compared with 10 for mass-spec protein.
The strongest signal is observed in lung squamous cell carcinoma (LUSC), where higher RNU7-174P Mutation is associated with worse overall survival. In most high-consensus cancer types, elevated RNU7-174P expression acts as an unfavorable survival marker.
LUSC are the cancer types where RNU7-174P Mutation most reproducibly stratifies survival.